A conversation with Centroflora CMS
Andrew Badrot, founder and CEO of Centroflora CMS, discussed the acquisition and technical transfer of Boehringer Ingelheim’s (BI) non-captive phytochemical API portfolio with Pharmaceutical Technology.
Centroflora CMS, a joint venture between phytochemicals expert Centroflora from Brazil and the Swiss contract manufacturing organization (CMO) CMS Pharma, won the CPhI 2015 award for excellence in partnering and outsourcing for the way it handled its acquisition and technical transfer of Boehringer Ingelheim’s (BI) non-captive phytochemical API portfolio in 2014. Andrew Badrot, founder and CEO of Centroflora CMS, discussed the project with Pharmaceutical Technology.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
